So what the hell have Starpharma been doing with DEP-HER2 ADC ? It appears to have not only stalled but regressed! Back in a 2020 presentation it was clearly identified as being in pre-clinical phase. Now in 2024 it is identified as being further back in research phase. (With the goal of advancing to pre-clinical.
This company is withering on a vine IMO.
Compare the 2 presentations below:
Ann: Australian Microcap Conference Presentation, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.005(4.55%) |
Mkt cap ! $48.09M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 12.0¢ | 11.5¢ | $32.48K | 277.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 103146 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 9328 | 3 |
View Market Depth
| Last trade - 15.09pm 12/08/2025 (20 minute delay) ? |
| SPL (ASX) Chart |